期刊文献+

CyclinE和cdk2在膀胱癌中表达及其临床意义 被引量:3

CLINICAL SIGNIFICANCE AND EXPRESSIONS OF CYCLIN E AND cdk2 IN BLADDER TRANSITIONAL CELL CARCINOMA
下载PDF
导出
摘要 探讨细胞周期蛋白E(cyclinE)和细胞周期蛋白依赖性激酶 2 (cdk2 )与膀胱癌发病的关系及其临床意义。方法 :应用免疫组化方法检测 16例正常膀胱组织和 88例膀胱移行细胞癌中cyclinE、cdk2和PCNA的表达。结果 :膀胱癌中cyclinE和cdk2表达均显著高于正常膀胱组织。cyclinE表达与膀胱癌病理分级、分期、复发和大小之间密切相关 ;cdk2表达则仅与肿瘤大小和PCNA指数密切相关。cyclinE和cdk2共同阳性表达者的肿瘤复发率明显增高。结论 :cyclinE和cdk2的异常表达在膀胱癌发生发展过程中起重要作用 ,两者共同表达对于术后病人监测及治疗方案的制定具有指导意义。 Objective:To study the expressions and the clinical significance of cyclin E and cyclin-dependent kinase 2 (cdk2) in bladder transitional cell carcinoma.Methods:The immunohistochemical method was adopted to detect cyclin E,cdk2 and PCNA expressions in 16 normal bladder tissues and 88 specimens of bladder cancer.Results:The higher expressions of cyclin E and cdk2 were found in blader cancer than those in normal blader tissues.Cyclin E expression was closely associated with tumor stage,grade,recurrence and size,respectively.cdK2 expression was merely positively related with tumor PCNA index and size,respectively.Higher tumor recurrence rate was found in the cases coexpressing both cyclin E and cdk2.Conclusions:Aberrant expression of cyclin E and cdk2 play important roles in development and progression of bladder cancer,and combining expression cyclin E expression and cdk2 is helpful for evaluating prognosis and making therapeutic options.
机构地区 解放军
出处 《中国现代医学杂志》 CAS CSCD 2001年第10期31-32,共2页 China Journal of Modern Medicine
关键词 膀胱肿瘤 细胞周期 细胞周期蛋白 免疫组织化学 Bladder Neoplasms Cell Cycle Cyclin Immunohistochemistry
  • 相关文献

参考文献8

  • 1[1]Clurman BE, Roberts JM. Cell cycle and cancer. J Nat Cancer Inst,1995;87: 1499~ 1501
  • 2[2]Grana X, Reddy EP. Cell cycle control in manmmalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth supressor genes and cyclin - dependent kinase inhibitors (CDKIs). Oncogene, 1995; 11:211~219
  • 3[3]Resnitzky D, Gossen M, Bujard H, et al. Acceleration of the GI/S phase transition by expression of cyclin D1 and E with an inducible system. Mol Cell Biol, 1994; 14: 1669 ~ 1679
  • 4[4]Shimizu M, Nikaido T,Toki T, et al. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas. Cancer, 1999; 85: 669~ 667
  • 5[5]Harwell RM, Porter DC, Danes C, et al. Processing of cyclin E differs bewteen normal and tumor breast cells. Cancer Res, 2000; 60: 481 ~489
  • 6[6]Biade S,Sobol RW,Wilson SH. Impairment of proliferating cell nuclear antigen dependent apurinic/apyrinidinic site repair on linear DNA. J Biol Chen, 1998; 273: 298 ~ 902
  • 7[7]Keyomarsi K, O' Leary N, Molnar G, et al. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res, 1995;54:380~385
  • 8[8]Fukuse T, Hirata T, Naiki H, et al. Prognostic significance of cyclin E overexpression in resected non - small cell lung cancer. Cancer Res, 2000: 60: 242~ 224

同被引文献11

  • 1Karsunky H, Geisen C, Schmidt T, et al. Oncogenic potential of cyclinE in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclinE and Ras but not Myc[J]. Oncogene, 1999, 18(54):7 816-7 824.
  • 2Marone M, Scambia G, Gianntteli C, et al. Analysis of cyclinE and CDK2 in ovarian cancer: Gene amplification and RNA overexpression[J]. Int J Cancer, 1998, 75:34-39.
  • 3Ahn MJ, Kim BH, Jang SJ, et al. Expression of cyclinD1 and E in human gastric carcinoma and its clinicopathologicsignificance[J]. J Korean Med Sci, 1998, 13(5):513-518.
  • 4Sutter T, Doi S, Camevale KA, et al. Expression of Cyclin D1 and E in human colon adenocarcinomas [J]. J Med,1997, 28(5-6) :285-309.
  • 5Culurmen BE, Roberts JM. Cell cycle and cancer[J]. J National Cancer Institute, 1995, 87(12) : 1 499-1 501.
  • 6Koff A, Cross F, Fisher A. Human CyelinE, a new cyclin that interacts with two members of the CDK2 gene family[J]. Cell, 1991, 66(6) : 1 217-1 228.
  • 7Gong J, Ardeh B, Traganos F, et al. Unscheduled expression of cyclinB1 and CyclinE in serval leukemic and solid tumor cell lines [J]. Cancer Res, 1994, 54(16):4285.
  • 8Mussman JG, Horn HF, Carroll DE, et al. Synergistic induction of centrosome hyperamplification by loss of p53 and CyclinE overexpression [J]. Oncogene, 2000, 19 (13) :1 635-1 646.
  • 9Li JQ, Miki H, Ohmori M, et al. Expression of CyclinE and Cyclin-dependent kinase 2 con-elates with metastasis and prognosis in colorectal carcinoma [J]. Hum Pathol,2001, 32(9) :945-953.
  • 10杨正平,石欣.Cyclin/Cdks复合物相关调控分子与肿瘤关系的研究进展[J].实用肿瘤学杂志,2008,22(2):185-188. 被引量:8

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部